TY  - GEN
AU  - Carducci,M A
AU  - Gilbert,J
AU  - Bowling,M K
AU  - Noe,D
AU  - Eisenberger,M A
AU  - Sinibaldi,V
AU  - Zabelina,Y
AU  - Chen,T L
AU  - Grochow,L B
AU  - Donehower,R C
TI  - A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule
SN  - 1078-0432
PY  - 2001///1205
KW  - Adult
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Chromatography, High Pressure Liquid
KW  - Disorders of Excessive Somnolence
KW  - chemically induced
KW  - Dose-Response Relationship, Drug
KW  - Fatigue
KW  - Female
KW  - Glutamine
KW  - analogs & derivatives
KW  - Humans
KW  - Hypokalemia
KW  - Infusions, Intravenous
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Nausea
KW  - Neoplasms
KW  - drug therapy
KW  - Neutropenia
KW  - Patient Dropouts
KW  - Phenylacetates
KW  - blood
KW  - Phenylbutyrates
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
KW  - Time Factors
KW  - Tumor Cells, Cultured
KW  - Uric Acid
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -